Acorda Therapeutics Inc (NASDAQ:ACOR)

29.77
Delayed Data
As of May 01
 -0.30 / -1.00%
Today’s Change
28.26
Today|||52-Week Range
45.45
-27.16%
Year-to-Date

Today’s Trading

Previous close30.07
Today’s open30.15
Day’s range28.81 - 30.61
Volume855,870
Average volume (3 months)769,905
Market cap$1.3B
Dividend yield--
Data as of 4:00pm ET, 05/01/2015

Growth & Valuation

Earnings growth (last year)+7.69%
Earnings growth (this year)-172.63%
Earnings growth (next 5 years)+18.00%
Revenue growth (last year)+19.34%
P/E ratio71.7
Price/Sales4.19
Price/Book2.31

Competitors

 Today’s
change
Today’s
% change
MACKMerrimack Pharmaceut...+0.82+7.39%
INSMInsmed Inc+1.16+5.79%
ZIOPZIOPHARM Oncology In...+0.71+8.06%
NLNKNewLink Genetics Cor...+2.04+4.57%
Data as of 4:00pm ET, 05/01/2015

Financials

Last reporting dateApril 30, 2015
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$401.5M
Annual profit (last year)$17.7M
Net profit margin4.40%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Chief-
Business Operations
David Lawrence
Corporate headquarters
Ardsley, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers